Article
Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.
Antimicrobial agents and chemotherapy - 1 Jun 2017
Cheng Lucy, Nelson Brian C, Mehta Monica, Seval Nikhil, Park Sarah, Giddins Marla J, Shi Qiuhu, Whittier Susan, Gomez-Simmonds Angela, Uhlemann Anne-Catrin
Abstract excerpt
In vivo induction of AmpC beta-lactamases produces high-level resistance to many beta-lactam antibiotics in Enterobacteriaceae, often resulting in the need to use carbapenems or cefepime (FEP). The clinical effectiveness of piperacillin-tazobactam (TZP), a weak inducer of AmpC beta-lactamases, is poorly understood. Here, we conducted a case-control study of adult inpatients with bloodstream infections (BSIs) due...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
